Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$194.08 USD
-2.89 (-1.47%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $194.30 +0.22 (0.11%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Charles River Laboratories (CRL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$220.64 | $250.00 | $190.00 | 12.02% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Charles River Laboratories comes to $220.64. The forecasts range from a low of $190.00 to a high of $250.00. The average price target represents an increase of 12.02% from the last closing price of $196.97.
Analyst Price Targets (14)
Broker Rating
Charles River Laboratories currently has an average brokerage recommendation (ABR) of 2.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 2.22 a month ago based on 18 recommendations.
Of the 17 recommendations deriving the current ABR, seven are Strong Buy, representing 41.18% of all recommendations. A month ago, Strong Buy represented 38.89%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 9 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 9 | 10 | 11 | 11 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 0 | 0 | 0 | 0 |
ABR | 2.29 | 2.18 | 2.22 | 2.22 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/1/2024 | Not Identified | Not Identified | Hold | Strong Sell |
8/12/2024 | Cowen & Co. | Charles Rhyee | Hold | Hold |
8/8/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Hold |
8/8/2024 | William Blair | Maxwell A Smock | Strong Buy | Strong Buy |
8/8/2024 | UBS | Dan Leonard | Strong Buy | Strong Buy |
8/8/2024 | Evercore Partners | Elizabeth Anderson | Strong Buy | Strong Buy |
6/28/2024 | Argus Research Corp. | David A Toung | Strong Buy | Hold |
6/28/2024 | Not Identified | Not Identified | Not Available | Hold |
6/7/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Not Available | Hold |
6/6/2024 | Goldman Sachs | Matthew Sykes | Not Available | Strong Buy |
5/6/2024 | Stephens | Jacob Johnson | Strong Buy | Strong Buy |
2/15/2024 | Guggenheim Securities | Jack D Wallace | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.29 |
ABR (Last week) | 2.18 |
# of Recs in ABR | 17 |
Average Target Price | $217.79 |
LT Growth Rate | 5.00% |
Industry | Medical Services |
Industry Rank by ABR | 190 of 252 |
Current Quarter EPS Est: | 2.42 |
CRL FAQs
Charles River Laboratories International, Inc. (CRL) currently has an average brokerage recommendation (ABR) of 2.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms.
The average price target for Charles River Laboratories International, Inc. (CRL) is $217.79. The current on short-term price targets is based on 9 reports.
The forecasts for Charles River Laboratories International, Inc. (CRL) range from a low of $175 to a high of $250. The average price target represents a increase of $12.22 from the last closing price of $194.08.
The current UPSIDE for Charles River Laboratories International, Inc. (CRL) is 12.22%
Based on short-term price targets offered by 14 analysts, the average price target for Charles River Laboratories comes to $220.64. The forecasts range from a low of $190.00 to a high of $250.00. The average price target represents an increase of 12.02% from the last closing price of $196.97.